glp 1 discovery of GLP-1–Based Drugs for the Treatment of Obesity GLP-1 medications are sparking new

If these medications were to be covered by private health plans or the public system, the potential market could expand to between 46 million and 100 million people, or 22% to 48% of Brazils population, according to a Santander report

doi: 10.1093/qjmed/hcs085 343 BurtonARRahmanKKadotaYLloydAVollmer-ConnaU

Instead of universal withholding, the guidance emphasized shared decision-making and targeted risk reduction for patients most likely to have delayed gastric emptying, such as those in the dose-escalation phase, those with notable gastrointestinal symptoms, those on higher doses, and those with comorbid conditions that slow gastric emptying

Take 3 capsules daily with a glass of water, preferably with a meal

Hepatoprotection and lethality rescue by histone deacetylase inhibitor valproic acid in fatal hemorrhagic shock

doi: 10.1038/s41593-021-00940-3 23 VachezYMTooleyJRAbiramanKMatikainen-AnkneyBCaseyEEarnestTet al